pharm-analyt was nominated for the innovation award “Kreativ in die Zukunft” ("Creatively Into the Future") in the category “Technical Innovation”.
The award is sponsered by the Austrian Economic Chamber. The final prize will be awarded on June 10th in St. Pölten.
pharm-analyt discovered and validated specific substances (Small Molecules) in plasma that indicate particular genetic disorders with remarkably high specificity and sensitivity.
Three of these biomarkers were submitted and nominated for this innovation award: For Gaucher’s Disease, Niemann-Pick Type C and Metachromatic Leucodystrophy.
All three have orphan status with an incidence rate of 1:20,000, 1:150,000 and 1:50,000, respectively.